Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Selling 50% of shares @$1.35 (one dollar, thirty five cents

<< Previous

Bullboard Posts

Next >>

Comment by Bigginvestoron Mar 18, 2021 5:57pm

289 Views

Post# 32832810

RE:RE:Selling 50% of shares @$1.35 (one dollar, thirty five cents

TradeMagician wrote:
PowerofNow wrote:
With so much noise on the board folks, you have to remember the psychology behind holding a stock and sticking to the ultimate goal. My sell order is at $1.35. No less.

PowerofNow: $1.36 is way too cheap for a compamy with so much raw potential. My goal is to sell half my shares at 10X your target. That's right, I'm not selling even a single share for less than $13.50/share. If you aren't thinking big then you are aleady a loser in this investing game. Think big if you want to be big.

lol wow $ 13 .shiiit that is big ok

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security